248 related articles for article (PubMed ID: 32319196)
1. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice.
Takashima S; Tanaka F; Kawaguchi Y; Usui Y; Fujimoto K; Nadatani Y; Otani K; Hosomi S; Nagami Y; Kamata N; Taira K; Tanigawa T; Watanabe T; Imoto S; Uematsu S; Fujiwara Y
Neurogastroenterol Motil; 2020 Jul; 32(7):e13841. PubMed ID: 32319196
[TBL] [Abstract][Full Text] [Related]
2. Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii.
Nadatani Y; Watanabe T; Suda W; Nakata A; Matsumoto Y; Kosaka S; Higashimori A; Otani K; Hosomi S; Tanaka F; Nagami Y; Kamata N; Taira K; Yamagami H; Tanigawa T; Hattori M; Fujiwara Y
Sci Rep; 2019 Nov; 9(1):17490. PubMed ID: 31767915
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
Wauters L; Ceulemans M; Frings D; Lambaerts M; Accarie A; Toth J; Mols R; Augustijns P; De Hertogh G; Van Oudenhove L; Tack J; Vanuytsel T
Gastroenterology; 2021 Apr; 160(5):1521-1531.e9. PubMed ID: 33346007
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
Macke L; Schulz C; Koletzko L; Malfertheiner P
Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
[TBL] [Abstract][Full Text] [Related]
6. Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia.
Wauters L; Tito RY; Ceulemans M; Lambaerts M; Accarie A; Rymenans L; Verspecht C; Toth J; Mols R; Augustijns P; Tack J; Vanuytsel T; Raes J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948413
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis.
Horvath A; Rainer F; Bashir M; Leber B; Schmerboeck B; Klymiuk I; Groselj-Strele A; Durdevic M; Freedberg DE; Abrams JA; Fickert P; Stiegler P; Stadlbauer V
Sci Rep; 2019 Aug; 9(1):12000. PubMed ID: 31427714
[TBL] [Abstract][Full Text] [Related]
8. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified.
Bruno G; Zaccari P; Rocco G; Scalese G; Panetta C; Porowska B; Pontone S; Severi C
World J Gastroenterol; 2019 Jun; 25(22):2706-2719. PubMed ID: 31235994
[TBL] [Abstract][Full Text] [Related]
10. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
[TBL] [Abstract][Full Text] [Related]
11. Integrated Analyses of the Gut Microbiota, Intestinal Permeability, and Serum Metabolome Phenotype in Rats with Alcohol Withdrawal Syndrome.
Yang F; Wei J; Shen M; Ding Y; Lu Y; Ishaq HM; Li D; Yan D; Wang Q; Zhang R
Appl Environ Microbiol; 2021 Aug; 87(18):e0083421. PubMed ID: 34190609
[TBL] [Abstract][Full Text] [Related]
12. Alteration of Colonic Mucosal Permeability during Antibiotic-Induced Dysbiosis.
Ran Y; Fukui H; Xu X; Wang X; Ebisutani N; Tanaka Y; Maeda A; Makizaki Y; Ohno H; Kondo T; Kono T; Tozawa K; Tomita T; Oshima T; Miwa H
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854266
[TBL] [Abstract][Full Text] [Related]
13. FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice.
Zhang Z; Lin T; Meng Y; Hu M; Shu L; Jiang H; Gao R; Ma J; Wang C; Zhou X
Metabolism; 2021 Jun; 119():154767. PubMed ID: 33753088
[TBL] [Abstract][Full Text] [Related]
14. The role of morphine- and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axis.
Muchhala KH; Kallurkar PS; Kang M; Koseli E; Poklis JL; Xu Q; Dewey WL; Fettweis JM; Jimenez NR; Akbarali HI
FASEB J; 2024 Apr; 38(8):e23603. PubMed ID: 38648368
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
Naito Y; Kashiwagi K; Takagi T; Andoh A; Inoue R
Digestion; 2018; 97(2):195-204. PubMed ID: 29316555
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Enterogermina's Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME Technology.
Duysburgh C; Verstrepen L; Broeck MVD; Righetto Z; Perez M
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771360
[TBL] [Abstract][Full Text] [Related]
17. Glucose but Not Fructose Alters the Intestinal Paracellular Permeability in Association With Gut Inflammation and Dysbiosis in Mice.
Zhang X; Monnoye M; Mariadassou M; Beguet-Crespel F; Lapaque N; Heberden C; Douard V
Front Immunol; 2021; 12():742584. PubMed ID: 35024040
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury.
Schneider KM; Elfers C; Ghallab A; Schneider CV; Galvez EJC; Mohs A; Gui W; Candels LS; Wirtz TH; Zuehlke S; Spiteller M; Myllys M; Roulet A; Ouzerdine A; Lelouvier B; Kilic K; Liao L; Nier A; Latz E; Bergheim I; Thaiss CA; Hengstler JG; Strowig T; Trautwein C
Cell Mol Gastroenterol Hepatol; 2021; 11(4):909-933. PubMed ID: 33189892
[TBL] [Abstract][Full Text] [Related]
19. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F
Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
